SCHEMBL15550259

SCHEMBL15550259

N#Cc1cccc(OCc2nc3c(cnn3C3CCCC3)c(=O)[nH]2)c1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 20/20 0.56
PDE1C Q14123 2/20 0.56
ACHE P22303 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30947514 1.00 PDE9A (0.56) PDE9APDE1CACHE
SCHEMBL15551426 0.90 PDE9A (0.60) PDE9APDE1CACHE
SCHEMBL15552324 0.88 PDE9A (0.71) PDE9APDE1CACHE
SCHEMBL15552268 0.86 PDE9A (0.70) PDE9APDE1CACHE
SCHEMBL15550624 0.86 PDE9A (0.61) PDE9APDE1CACHE
SCHEMBL30947484 0.86 PDE9A (0.61) PDE9APDE1CACHE
SCHEMBL15550257 0.84 PDE9A (0.62) PDE9APDE1CACHE
SCHEMBL15551033 0.83 PDE9A (0.61) PDE9APDE1CACHE
SCHEMBL15550706 0.79 PDE9A (0.73) PDE9APDE1C
SCHEMBL15551640 0.77 PDE9A (0.64) PDE9APDE1CACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014016789-A1 PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE DERIVATIVES AS PDE9 INHIBITORS CELON PHARMA S.A. (PL) 2014-01-30 WO claimed
WO-2024107445-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES FREEDOM BIOSCIENCES, INC. (US) 2024-05-23 WO disclosed
WO-2014016789-A1 PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE DERIVATIVES AS PDE9 INHIBITORS CELON PHARMA S.A. (PL) 2014-01-30 WO disclosed